Schrodinger, Inc. (SDGR) Q2 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Schrodinger, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.740 -- 00:00:05.325 Thank you for standing by. Welcome to Schrodinger's conference call to review second 00:00:05.325 -- 00:00:10.290 quarter 2025 financial results. My name is Rob and I'll be your operator for today's 00:00:10.290 -- 00:00:14.454 call. All lines have been placed on mute to prevent any background noise. 00:00:14.454 -- 00:00:17.717 After the speaker's remarks, there will be a question and answer session. 00:00:17.717 -- 00:00:21.041 If you would like to ask a question during this time, simply press star followed by the 00:00:21.041 -- 00:00:25.285 number one on your telephone keypad. If you would like to withdraw your question, again, 00:00:25.285 -- 00:00:30.642 press star one. Please be advised that this call is being recorded at the company's request. 00:00:30.642 -- 00:00:33.846 Now I would like to introduce your host for today's conference, Ms. 00:00:33.846 -- 00:00:38.192 Jaron Madden, Chief Corporate Affairs Officer and Head of Investor Relations. 00:00:38.192 -- 00:00:40.255 Please go ahead. 00:00:40.255 -- 00:00:44.240 Thank you, and good afternoon, everyone. Welcome to today's call, during which we will 00:00:44.240 -- 00:00:49.367 provide an update on the company and review our second quarter 2025 financial results. 00:00:49.367 -- 00:00:53.453 Earlier today, we issued a press release summarizing our financial results and progress 00:00:53.453 -- 00:00:58.199 across the company, which is available on our website at schrodinger.com. 00:00:58.199 -- 00:01:03.587 Here with me on our call today are Rami Fareed, Chief Executive Officer, Richie Jane, 00:01:03.587 -- 00:01:08.655 Chief Financial Officer, and Karen Akinsanya, President, Head of Therapeutics, R&D, and 00:01:08.655 -- 00:01:12.962 Chief Strategy Officer, Partnerships...